Pentokey Organy (India) (BOM:524210) ROCE %: -5.40% (As of Mar. 2026)


BOM:524210 Pentokey Organy (India) Ltd BOM:524210
49 GF Score
Price ₹37.00
GF Value ₹26.22
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Pentokey Organy (India) ROCE %?

Pentokey Organy (India) BOM:524210 -3.52% 49 ROCE % is -5.40% as of Mar. 2026. GuruFocus rates BOM:524210 with a GF Score™ of 49/100 and a GF Value™ of ₹26.22 (Significantly Overvalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pentokey Organy (India)'s annualized ROCE % for the quarter that ended in Mar. 2026 was -5.40%.


Pentokey Organy (India)  (BOM:524210) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Pentokey Organy (India) ROCE % Related Terms


Pentokey Organy (India) ROCE % Historical Data

* Premium members only.

The historical data trend for Pentokey Organy (India)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentokey Organy (India) ROCE % Chart

Pentokey Organy (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.09 47.18 9.96 2.65 2.13

Pentokey Organy (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 20.50 5.57 -11.47 -5.40
BOM:524210
49GF Score
Pentokey Organy (India) Ltd BOM:524210
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentokey Organy (India) ROCE % Calculation

Pentokey Organy (India)'s annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=2.039/( ( (97.857 - 3.285) + (94.384 - -2.504) )/ 2 )
=2.039/( (94.572+96.888)/ 2 )
=2.039/95.73
=2.13 %

Pentokey Organy (India)'s ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-5.232/( ( (0 - 0) + (94.384 - -2.504) )/ 1 )
=-5.232/( ( 0 + 96.888 )/ 1 )
=-5.232/96.888
=-5.40 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -5.40% mean?
Pentokey Organy (India) (BOM:524210) has a ROCE % of -5.40% as of Mar. 2026.
Is Pentokey Organy (India)'s ROCE % too high?
Pentokey Organy (India)'s current ROCE % is -5.40%. Overall, Pentokey Organy (India) has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pentokey Organy (India)'s ROCE % compare to DOW?
Pentokey Organy (India)'s ROCE % of -5.40% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.42, based on 1,589 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pentokey Organy (India)'s current ROCE % is -5.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentokey Organy (India) stock overvalued right now?
Based on GuruFocus' analysis, Pentokey Organy (India) (BOM:524210) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹26.22, compared to a current price of ₹37.00 — trading 41.1% above its estimated fair value. The current ROCE % is -5.40%. Pentokey Organy (India)'s overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Pentokey Organy (India) (BOM:524210), the current ROCE % is -5.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pentokey Organy (India) (BOM:524210) Overvalued in 2026?

Based on GuruFocus' analysis, Pentokey Organy (India) stock appears to be overvalued. The current stock price of ₹37.00 is trading 41.1% above its estimated GF Value™ of ₹26.22. GuruFocus considers Pentokey Organy (India) to be Significantly Overvalued.

Key valuation signals for BOM:524210:

  • ROCE %: -5.40%
  • GF Value™: ₹26.22 vs. price of ₹37.00 (41.1% above fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the BOM:524210 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pentokey Organy (India) Business Description

Address Off Western Express Highway, 509, Western Edge I, Borivali (East), Food Corporation of India Warehouse, Mumbai, MH, IND, 400066
Pentokey Organy (India) Ltd is engaged in the trading of Pharmaceutical Goods. It manufactures various chemical products such as Acetic acid, Ethyl acetate, and Acetaldehyde and Butyl acetate. These products are used for various purposes including textile processing, pharmaceuticals, pesticides, printing inks, paints, and coatings, perfumes, polyester resins and basic dyes, solvents and many more. The only segment in which the Company engaged in the Trading of Pharmaceutical Products.
49GF Score

Get the complete analysis for BOM:524210

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.00
Price
₹26.22
GF Value